Search Results for: results
AP2S1 Gene Hypocalciuric Hypercalcemia Familial Type 3 Genetic Test Cost
The AP2S1 gene plays a critical role in calcium regulation within the body, and mutations in this gene can lead to a rare condition known as familial hypocalciuric hypercalcemia type 3 (FHH3). This genetic disorder is characterized by elevated calcium levels in the blood while maintaining low levels of calcium in the urine, a condition that can lead to various health issues if not properly managed. To diagnose FHH3, a genetic test targeting the AP2S1 gene is available at DNA Labs UAE. This test involves analyzing the DNA to identify mutations in the AP2S1 gene that are responsible for the condition. It is a crucial step for families with a history of hypercalcemia to understand their genetic makeup and manage the condition effectively. The cost of the AP2S1 gene hypocalciuric hypercalcemia familial type 3 genetic test at DNA Labs UAE is 4400 AED. This investment allows individuals and families to gain valuable insights into their genetic predisposition to FHH3, facilitating early intervention and personalized management strategies to mitigate the impact of this condition on their health and lifestyle.
LDLR Gene Hypercholesterolemia Due to LDL-Receptor-Disorder Autosomal Dominant Genetic Test Cost
The LDLR gene is crucial in the body's management of cholesterol levels. It encodes the low-density lipoprotein receptor, which is responsible for removing LDL cholesterol (often referred to as "bad" cholesterol) from the bloodstream. Hypercholesterolemia due to LDL-receptor disorder is a condition where mutations in the LDLR gene impair this process, leading to elevated levels of LDL cholesterol. This condition is typically inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene can cause the disorder. In individuals with a family history of hypercholesterolemia or early heart disease, genetic testing for LDLR gene mutations can be crucial for early diagnosis and management. DNA Labs UAE offers a specific test aimed at identifying mutations in the LDLR gene that are associated with this form of hypercholesterolemia. The test is priced at 4400 AED and involves analyzing the patient's DNA to detect any genetic alterations that may affect the function of the LDL receptor. Early identification of individuals carrying LDLR gene mutations allows for timely intervention, which may include lifestyle modifications and pharmacological treatment to manage cholesterol levels and reduce the risk of heart disease. This test is an important tool in the proactive management of inherited hypercholesterolemia, offering a pathway towards personalized medical care for affected individuals and their families.
APOB Gene Hypercholesterolemia Type B Autosomal Dominant Genetic Test Cost
The APOB Gene Hypercholesterolemia Type B Autosomal Dominant Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the APOB gene, which are associated with Familial Hypercholesterolemia Type B. This condition is characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C) in the blood, leading to an increased risk of coronary artery disease. The test is crucial for individuals with a family history of hypercholesterolemia or early heart disease, as it enables early detection and the implementation of targeted interventions to manage cholesterol levels and reduce cardiovascular risk. Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab. The DNA is then analyzed to detect specific mutations in the APOB gene that are known to cause the condition. The results can provide valuable information for affected individuals and their families regarding the management of their cholesterol levels and the prevention of heart disease. The cost of the APOB Gene Hypercholesterolemia Type B Autosomal Dominant Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the information gained from this test can be invaluable in guiding healthcare decisions and lifestyle modifications to mitigate the impact of this genetic condition. It is advisable for potential clients to consult with their healthcare provider to understand the implications of the test results fully and to determine if this test is appropriate for their specific situation.
EPHX2 Gene Hypercholesterolemia Familial Due to LDLR Defect Modifier of Genetic Test Cost
The EPHX2 gene, associated with the metabolism of cholesterol in the body, plays a significant role in the development of familial hypercholesterolemia (FH), particularly in individuals with defects in the LDLR gene. Familial hypercholesterolemia is a genetic disorder characterized by high cholesterol levels, specifically low-density lipoprotein (LDL) cholesterol, leading to an increased risk of heart disease from a young age. The LDLR gene encodes the LDL receptor, which is crucial for the clearance of LDL cholesterol from the blood. Mutations in the LDLR gene reduce the body's ability to remove LDL cholesterol, resulting in its accumulation. Given the complex interplay between various genes in lipid metabolism and cardiovascular disease risk, individuals with familial hypercholesterolemia due to LDLR defects may benefit from a comprehensive genetic analysis, including the assessment of the EPHX2 gene. This analysis can provide insights into the severity of the condition and potential response to treatment strategies. In the UAE, DNA Labs offers a specialized genetic test that examines the EPHX2 gene among others to identify modifications that may influence the clinical presentation and management of familial hypercholesterolemia in the context of LDLR defects. The test, priced at 4400 AED, is a valuable tool for personalized medicine, enabling healthcare providers to tailor treatment plans based on the patient's genetic makeup, thereby optimizing outcomes and potentially reducing the risk of cardiovascular events.
APOA2 Gene Hypercholesterolemia Familial Modifier of Genetic Test Cost
The APOA2 gene, associated with the apolipoprotein A-II protein, plays a significant role in lipid metabolism and has been identified as a potential modifier in the development of familial hypercholesterolemia (FH). Familial hypercholesterolemia is a genetic disorder characterized by high cholesterol levels from birth, increasing the risk of heart disease at an early age. The interaction between APOA2 variants and other genetic factors can influence the severity and treatment response of FH, making the understanding of its role crucial for personalized medicine. To assess the impact of the APOA2 gene on familial hypercholesterolemia, a specific genetic test is available at DNA Labs UAE. This test is designed to identify variations in the APOA2 gene that could modify the clinical presentation and treatment outcomes of FH. By understanding these genetic nuances, healthcare providers can tailor treatment plans more effectively, potentially improving patient outcomes. The cost of the APOA2 gene hypercholesterolemia familial modifier genetic test at DNA Labs UAE is 4400 AED. This test is a valuable tool for individuals with a family history of hypercholesterolemia or early-onset heart disease, offering insights that could lead to more effective management of their condition.
ITIH4 Gene Hypercholesterolemia Susceptibility to Genetic Test Cost
The ITIH4 gene, known for its role in the inflammatory response and vascular leakage, has been identified as a potential marker for susceptibility to hypercholesterolemia, a condition characterized by high levels of cholesterol in the blood. This condition can significantly increase the risk of heart disease and stroke, making early detection and management crucial. DNA Labs UAE offers a specialized genetic test aimed at identifying variations in the ITIH4 gene that may indicate an increased risk of developing hypercholesterolemia. By analyzing specific segments of DNA, this test can provide individuals with valuable insights into their genetic predisposition to this condition, enabling them to take proactive steps towards managing their cholesterol levels and reducing their risk of cardiovascular diseases. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately assess the ITIH4 gene's role in hypercholesterolemia susceptibility. Conducted in state-of-the-art facilities, this test represents a critical tool in personalized medicine, offering a tailored approach to disease prevention and health management based on an individual's unique genetic makeup.
PPP1R17 Gene Hypercholesterolemia Susceptibility to Genetic Test Cost
The PPP1R17 gene, associated with the regulation of lipid metabolism pathways, has recently been identified as a potential factor influencing an individual's susceptibility to hypercholesterolemia. Hypercholesterolemia, characterized by high levels of cholesterol in the blood, significantly increases the risk of cardiovascular diseases. Understanding the genetic predisposition to this condition can be crucial in its early detection and management. DNA Labs UAE offers a specialized genetic test targeting the PPP1R17 gene to assess the risk of developing hypercholesterolemia. This test is particularly recommended for individuals with a family history of hypercholesterolemia or cardiovascular diseases, aiming to provide a personalized risk assessment that can guide lifestyle and medical interventions. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise involved in analyzing the genetic markers associated with hypercholesterolemia susceptibility. Conducted in a state-of-the-art laboratory setting, the process involves collecting a DNA sample, typically through a non-invasive method such as a saliva swab or blood draw, followed by a detailed analysis of the PPP1R17 gene. Results from this test can offer valuable insights into an individual's genetic predisposition to hypercholesterolemia, enabling proactive health management strategies. It is, however, important to note that genetic predisposition is just one of many factors that can contribute to the development of hypercholesterolemia, and results should be interpreted in conjunction with other clinical assessments and lifestyle considerations.
APOA5 Gene Hyperchylomicronemia Type 5 Genetic Test Cost
The APOA5 Gene Hyperchylomicronemia Type 5 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the APOA5 gene, which are linked to Type 5 Hyperchylomicronemia, a rare genetic disorder. This condition is characterized by an inability to properly break down fats, leading to a significant increase in the levels of chylomicrons in the blood, which can result in pancreatitis, abdominal pain, and an increased risk of cardiovascular disease. The test is critical for individuals who exhibit symptoms of the disorder or have a family history of hyperlipidemia, as early detection can lead to more effective management and treatment strategies. Conducted at DNA Labs UAE, a leading facility in genetic testing, the cost of the test is 4400 AED. This investment in health allows for a comprehensive understanding of one's genetic predisposition to this condition, enabling targeted interventions and personalized healthcare planning.
